CPH 0.00% 0.9¢ creso pharma limited

Ann: Strategic Collaboration for CBD products with Hempmate Switz, page-4

  1. 4,558 Posts.
    lightbulb Created with Sketch. 161
    yes,,...not particularly price sensitive.
    Lots of collaborations.....lots of spending, and little income.
    However, of all the various cannabis companies, I have a reasonably good feeling about this company. They are driving towards a European presence,
    They aren't pretending to be the answer to all medical problems with CBD oil....with or without THC.
    They aren't trying to be the biggest rec. cannabis producer. Just trying to get a foothold into the market....and find what works and what doesn't.
    Unfortunately, That all takes time, and people don't want to  see the SP wane as it does with little income and lots of spending.  But that is the nature of company value.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.